VIJ Digital library
Articles

Generative AI to Predict Breast Cancer: Current Approaches, Advancements, and Challenges

Alma Mohapatra
AIML and Generative AI

Submission to VIJ 2024-11-08

Keywords

  • Generative AI, Breast Cancer Prediction, Medical Imaging, Generative Adversarial Networks (GANs), Variational Autoencoders (VAEs), Multi-Modal Data Integration, Healthcare AI, Predictive Modeling, Medical Image Analysis

Abstract

Breast cancer is one of the most prevalent cancers worldwide, with early detection playing a critical role in improving patient outcomes and survival rates. Traditional diagnostic methods, though effective, often face challenges in terms of accessibility, cost, and the need for highly skilled radiologists. Recent advancements in Artificial Intelligence (AI), particularly Generative AI (GAI), have opened new avenues in medical imaging and predictive analysis. Unlike conventional AI models, Generative AI can produce synthetic data that mimics real mammograms, providing a robust solution to data scarcity and enhancing model training.

This paper explores the application of Generative AI, especially Generative Adversarial Networks (GANs) and Variational Autoencoders (VAEs), in predicting breast cancer through synthetic imaging and data augmentation techniques. By generating high-quality synthetic breast cancer imaging data, GAI models can improve diagnostic accuracy and sensitivity. We review recent studies and case examples where Generative AI has demonstrated efficacy in predicting and detecting breast cancer at early stages, often outperforming traditional AI models. In addition, we provide a technical overview of the workflow involved in training and deploying GAI models for breast cancer prediction, highlighting steps from data acquisition and preprocessing to model evaluation.

The findings suggest that while Generative AI holds significant promise in predictive oncology, it also faces challenges related to model interpretability, data bias, and ethical considerations. We discuss these limitations and propose strategies to address them, focusing on the need for diversified data sources, model transparency, and collaboration between data scientists and healthcare professionals. The paper concludes with an outlook on future advancements in Generative AI, including the integration of newer models such as diffusion models, and emphasizes the potential of these technologies to revolutionize cancer diagnostics by providing cost-effective, accessible, and highly accurate predictive tools for breast cancer.

References

  1. Zhang, F., Zhang, Y., Zhu, X., Chen, X., Du, H., & Zhang, X. (2022). PregGAN: A prognosis prediction model for breast cancer based on conditional generative adversarial networks. Computer Methods and programs in Biomedicine, 224, 107026.
  2. Ghose, S., Cho, S., Ginty, F., McDonough, E., Davis, C., Zhang, Z., ... & Badve, S. S. (2023). Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model. Cancers, 15(7), 1922.
  3. Inan, M. S. K., Hossain, S., & Uddin, M. N. (2023). Data augmentation guided breast cancer diagnosis and prognosis using an integrated deep-generative framework based on breast tumor’s morphological information. Informatics in Medicine Unlocked, 37, 101171.
  4. Ghebrehiwet, I., Zaki, N., Damseh, R., & Mohamad, M. S. (2024). Revolutionizing personalized medicine with generative AI: a systematic review. Artificial Intelligence Review, 57(5), 1-41.
  5. Derbal, Y. (2024). Adaptive Cancer Therapy in the Age of Generative Artificial Intelligence. Cancer Control, 31, 10732748241264704.
  6. Arya, N., & Saha, S. (2021). Generative incomplete multi-view prognosis predictor for breast cancer: GIMPP. IEEE/ACM Transactions on Computational Biology and Bioinformatics, 19(4), 2252-2263.
  7. Das, A., Devarampati, V. K., & Nair, M. S. (2021). NAS-SGAN: a semi-supervised generative adversarial network model for atypia scoring of breast cancer histopathological images. IEEE Journal of Biomedical and Health Informatics, 26(5), 2276-2287.
  8. Xiao, Y., Wu, J., & Lin, Z. (2021). Cancer diagnosis using generative adversarial networks based on deep learning from imbalanced data. Computers in Biology and Medicine, 135, 104540.
  9. Ahn, J. S., Shin, S., Yang, S. A., Park, E. K., Kim, K. H., Cho, S. I., ... & Kim, S. (2023). Artificial intelligence in breast cancer diagnosis and personalized medicine. Journal of Breast Cancer, 26(5), 405.
  10. Guttà, C., Morhard, C., & Rehm, M. (2023). Applying a GAN-based classifier to improve transcriptome-based prognostication in breast cancer. PLOS Computational Biology, 19(4), e1011035.
  11. Strelcenia, E., & Prakoonwit, S. (2023). Improving cancer detection classification performance using GANs in breast cancer data. IEEE Access.
  12. Shivhare, E., & Saxena, V. (2022). Optimized generative adversarial network based breast cancer diagnosis with wavelet and texture features. Multimedia Systems, 28(5), 1639-1655.
  13. Zhang, J., Wu, J., Zhou, X. S., Shi, F., & Shen, D. (2023, September). Recent advancements in artificial intelligence for breast cancer: Image augmentation, segmentation, diagnosis, and prognosis approaches. In Seminars in Cancer Biology. Academic Press.
  14. Ibrahim, M. A., Elgassim, M. A., Abdelrahman, A., Sati, W., Zaki, H. A., & Elgassim, M. (2023). Broken Heart: A Clear Case of Takotsubo Cardiomyopathy. Cureus, 15(11).
  15. Yusuf, G. T. P., Şimşek, A. S., Setiawati, F. A., Tiwari, G. K., & Kianimoghadam, A. S. (2024). Validation of the Interpersonal Forgiveness Indonesian Scale: An examination of its psychometric properties using confirmatory factor analysis. Psikohumaniora: Jurnal Penelitian Psikologi, 9(1).
  16. Zaki, H. A., Albaroudi, B., Shaban, E. E., Shaban, A., Elgassim, M., Almarri, N. D., ... & Azad, A. M. (2024). Advancement in pleura effusion diagnosis: a systematic review and meta-analysis of point-of-care ultrasound versus radiographic thoracic imaging. The Ultrasound Journal, 16(1), 3.
  17. Khabibullaev, T. (2024). Navigating the Ethical, Organizational, and Societal Impacts of Generative AI: Balancing Innovation with Responsibility. Zenodo. https://doi.org/10.5281/zenodo.13995243
  18. Zaki, H. A., Iftikhar, H., Najam, M., Masood, M., Al-Marri, N. D. R., & Elgassim, M. A. M. & Shaban, EE (2023). Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain-Barré syndrome (GBS) in patients with severe symptoms: A systematic review and meta-analysis.
  19. Zaki, H. A., Iftikhar, H., Najam, M., Masood, M., Al-Marri, N. D. R., Elgassim, M. A. M., ... & Shaban, E. E. (2023). Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain-Barré syndrome (GBS) in patients with severe symptoms: A systematic review and meta-analysis. Eneurologicalsci, 31, 100468.
  20. Zaki, H. A., Iftikhar, H., Abdalrubb, A., Al-Marri, N. D. R., Abdelrahim, M. G., Fayed, M., ... & Elarref, M. A. (2022). Clinical assessment of intermittent fasting with ketogenic diet in glycemic control and weight reduction in patients with type II diabetes mellitus: a systematic review and meta-analysis. Cureus, 14(10).